Invirase labeling updated to include cardiac risk with Norvir - ONA
Links shared publicly online about this topic.
- 785total visits
Invirase labeling updated to include cardiac risk with Norvir - ONA
The FDA announced that new safety information has been added to the label for Invirase (saquinavir, from Genentech), describing potentially life-threatening cardiac effects when used with Norvir (ritonavir, from Abbott).
View full resource at oncologynurseadvisor.com
Tags: Heart, HIV Medication, FDA, Norvir, Invirase, Genentech, Safety
Most Recently Shared on October 21, 2010 at 7:21 pm By:
Invirase labeling updated to include cardiac risk with Norvir http://goo.gl/fb/3HTNM
Invirase labeling updated to include cardiac risk with Norvir - MPR
empr.com — “The FDA announced that new safety information has been added to the label for Invirase (saquinavir, from Genentech), describing potentially life-threatening cardiac effects when used with Norvir (ritonavir, from Abbott).” View full resource at empr.com
Most Recently Shared on October 21, 2010 at 9:06 pm By:
MPR News: Invirase labeling updated to include cardiac risk with Norvir: The FDA announced that new safety informa... http://bit.ly/9u5okh
Advertisement
